These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 10639349)

  • 41. Evidence for a continuum of decreased vancomycin susceptibility in unselected Staphylococcus aureus clinical isolates.
    Hussain FM; Boyle-Vavra S; Shete PB; Daum RS
    J Infect Dis; 2002 Sep; 186(5):661-7. PubMed ID: 12195353
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparative bactericidal activities of daptomycin and vancomycin against glycopeptide-intermediate Staphylococcus aureus (GISA) and heterogeneous GISA isolates.
    Wootton M; MacGowan AP; Walsh TR
    Antimicrob Agents Chemother; 2006 Dec; 50(12):4195-7. PubMed ID: 17043121
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Activity of moxifloxacin in combination with vancomycin or teicoplanin against Staphylococcus aureus isolated from device-associated infections unresponsive to glycopeptide therapy.
    Tarasi A; Cassone M; Monaco M; Tarasi D; Pompeo ME; Venditti M
    J Chemother; 2003 Jun; 15(3):239-43. PubMed ID: 12868549
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bactericidal activities of two daptomycin regimens against clinical strains of glycopeptide intermediate-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus faecium, and methicillin-resistant Staphylococcus aureus isolates in an in vitro pharmacodynamic model with simulated endocardial vegetations.
    Akins RL; Rybak MJ
    Antimicrob Agents Chemother; 2001 Feb; 45(2):454-9. PubMed ID: 11158740
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prevalence of Staphylococcus aureus and coagulase-negative staphylococci with decreased sensitivity to glycopeptides as assessed by determination of MICs.
    Vedel G; Leruez M; Lémann F; Hraoui E; Ratovohery D
    Eur J Clin Microbiol Infect Dis; 1990 Nov; 9(11):820-2. PubMed ID: 2150815
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antimicrobial susceptibility of coagulase-negative staphylococci and characterization of isolates with reduced susceptibility to glycopeptides.
    Del' Alamo L; Cereda RF; Tosin I; Miranda EA; Sader HS
    Diagn Microbiol Infect Dis; 1999 Jul; 34(3):185-91. PubMed ID: 10403098
    [TBL] [Abstract][Full Text] [Related]  

  • 47. DNA microarray-based identification of genes associated with glycopeptide resistance in Staphylococcus aureus.
    Cui L; Lian JQ; Neoh HM; Reyes E; Hiramatsu K
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3404-13. PubMed ID: 16048954
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In vivo development of decreased susceptibility to vancomycin in clinical isolates of methicillin-resistant Staphylococcus aureus.
    Sugino Y; Iinumab Y; Ichiyama S; Ito Y; Ohkawa S; Nakashima N; Shimokata K; Hasegawa Y
    Diagn Microbiol Infect Dis; 2000 Nov; 38(3):159-67. PubMed ID: 11109014
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Resistance to autolysis in vancomycin-selected Staphylococcus aureus isolates precedes vancomycin-intermediate resistance.
    Boyle-Vavra S; Challapalli M; Daum RS
    Antimicrob Agents Chemother; 2003 Jun; 47(6):2036-9. PubMed ID: 12760894
    [TBL] [Abstract][Full Text] [Related]  

  • 50. First report of methicillin-resistant Staphylococcus aureus with reduced susceptibility to vancomycin in Thailand.
    Trakulsomboon S; Danchaivijitr S; Rongrungruang Y; Dhiraputra C; Susaemgrat W; Ito T; Hiramatsu K
    J Clin Microbiol; 2001 Feb; 39(2):591-5. PubMed ID: 11158112
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Glycopeptide susceptibility profiles of Staphylococcus haemolyticus bloodstream isolates.
    Biavasco F; Vignaroli C; Lazzarini R; Varaldo PE
    Antimicrob Agents Chemother; 2000 Nov; 44(11):3122-6. PubMed ID: 11036034
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Increasing resistance to vancomycin and other glycopeptides in Staphylococcus aureus.
    Tenover FC; Biddle JW; Lancaster MV
    Emerg Infect Dis; 2001; 7(2):327-32. PubMed ID: 11294734
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of prolonged vancomycin administration on methicillin-resistant Staphylococcus aureus (MRSA) in a patient with recurrent bacteraemia.
    Sakoulas G; Gold HS; Cohen RA; Venkataraman L; Moellering RC; Eliopoulos GM
    J Antimicrob Chemother; 2006 Apr; 57(4):699-704. PubMed ID: 16464892
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Investigation of Staphylococcus strains with heterogeneous resistance to glycopeptides in a Turkish university hospital.
    Nakipoglu Y; Derbentli S; Cagatay AA; Katranci H
    BMC Infect Dis; 2005 May; 5():31. PubMed ID: 15871748
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characterization of staphylococci with reduced susceptibilities to vancomycin and other glycopeptides.
    Tenover FC; Lancaster MV; Hill BC; Steward CD; Stocker SA; Hancock GA; O'Hara CM; McAllister SK; Clark NC; Hiramatsu K
    J Clin Microbiol; 1998 Apr; 36(4):1020-7. PubMed ID: 9542929
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Occurrence of vancomycin-intermediate-resistant Staphylococcus aureus in Japan.
    Hanaki H; Hososaka Y; Yanagisawa C; Otsuka Y; Nagasawa Z; Nakae T; Sunakawa K
    J Infect Chemother; 2007 Apr; 13(2):118-21. PubMed ID: 17458681
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In vitro activity of fosfomycin in combination with vancomycin or teicoplanin against Staphylococcus aureus isolated from device-associated infections unresponsive to glycopeptide therapy.
    Pistella E; Falcone M; Baiocchi P; Pompeo ME; Pierciaccante A; Penni A; Venditti M
    Infez Med; 2005 Jun; 13(2):97-102. PubMed ID: 16220029
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A multicenter study evaluating the current strategies for isolating Staphylococcus aureus strains with reduced susceptibility to glycopeptides.
    Wootton M; MacGowan AP; Walsh TR; Howe RA
    J Clin Microbiol; 2007 Feb; 45(2):329-32. PubMed ID: 17108069
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Characterization of Staphylococcus aureus isolates with decreased susceptibility to vancomycin and teicoplanin: isolation and purification of a constitutively produced protein associated with decreased susceptibility.
    Daum RS; Gupta S; Sabbagh R; Milewski WM
    J Infect Dis; 1992 Nov; 166(5):1066-72. PubMed ID: 1402017
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Glycopeptide resistant Staphylococcus.
    Witte W
    J Vet Med B Infect Dis Vet Public Health; 2004; 51(8-9):370-3. PubMed ID: 15525368
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.